178 related articles for article (PubMed ID: 27621837)
21. Advances in the Management of Central Nervous System Metastases in Non-Small Cell Lung Cancer.
D'Aiello A; Miao E; Cheng H
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765802
[TBL] [Abstract][Full Text] [Related]
22. Assessment of Brain Tumor Response: RANO and Its Offspring.
Eisele SC; Wen PY; Lee EQ
Curr Treat Options Oncol; 2016 Jul; 17(7):35. PubMed ID: 27262709
[TBL] [Abstract][Full Text] [Related]
23. Leptomeningeal metastases from solid tumors: A SNO and ASCO consensus review on clinical management and future directions.
Wilcox JA; Chukwueke UN; Ahn MJ; Aizer AA; Bale TA; Brandsma D; Brastianos PK; Chang S; Daras M; Forsyth P; Garzia L; Glantz M; Oliva ICG; Kumthekar P; Le Rhun E; Nagpal S; O'Brien B; Pentsova E; Lee EQ; Remsik J; Rudà R; Smalley I; Taylor MD; Weller M; Wefel J; Yang JT; Young RJ; Wen PY; Boire AA;
Neuro Oncol; 2024 Jun; ():. PubMed ID: 38902944
[TBL] [Abstract][Full Text] [Related]
24. Emergent radiotherapy for brain and leptomeningeal metastases: a narrative review.
Barbour AB; Zaki P; McGranahan TM; Venur V; Vellayappan B; Palmer J; Halasz LM; Yang JT; Blau M; Tseng YD; Chao ST; Suh JH; Foote M; Redmond KJ; Combs SE; Chang EL; Sahgal A; Lo SS
Ann Palliat Med; 2023 Nov; 12(6):1405-1419. PubMed ID: 37431225
[TBL] [Abstract][Full Text] [Related]
25. Management of single brain metastasis: a practice guideline.
Mintz A; Perry J; Spithoff K; Chambers A; Laperriere N
Curr Oncol; 2007 Aug; 14(4):131-43. PubMed ID: 17710205
[TBL] [Abstract][Full Text] [Related]
26. Non-small cell lung cancer (NSCLC) and central nervous system (CNS) metastases: role of tyrosine kinase inhibitors (TKIs) and evidence in favor or against their use with concurrent cranial radiotherapy.
Economopoulou P; Mountzios G
Transl Lung Cancer Res; 2016 Dec; 5(6):588-598. PubMed ID: 28149754
[TBL] [Abstract][Full Text] [Related]
27. The role of brain radiotherapy for EGFR- and ALK-positive non-small-cell lung cancer with brain metastases: a review.
Nardone V; Romeo C; D'Ippolito E; Pastina P; D'Apolito M; Pirtoli L; Caraglia M; Mutti L; Bianco G; Falzea AC; Giannicola R; Giordano A; Tagliaferri P; Vinciguerra C; Desideri I; Loi M; Reginelli A; Cappabianca S; Tassone P; Correale P
Radiol Med; 2023 Mar; 128(3):316-329. PubMed ID: 36786970
[TBL] [Abstract][Full Text] [Related]
28. Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank.
Chuntova P; Chow F; Watchmaker PB; Galvez M; Heimberger AB; Newell EW; Diaz A; DePinho RA; Li MO; Wherry EJ; Mitchell D; Terabe M; Wainwright DA; Berzofsky JA; Herold-Mende C; Heath JR; Lim M; Margolin KA; Chiocca EA; Kasahara N; Ellingson BM; Brown CE; Chen Y; Fecci PE; Reardon DA; Dunn GP; Liau LM; Costello JF; Wick W; Cloughesy T; Timmer WC; Wen PY; Prins RM; Platten M; Okada H
Neuro Oncol; 2021 Mar; 23(3):356-375. PubMed ID: 33367885
[TBL] [Abstract][Full Text] [Related]
29. Brain metastases in patients diagnosed with a solid primary cancer during childhood: experience from a single referral cancer center.
Suki D; Khoury Abdulla R; Ding M; Khatua S; Sawaya R
J Neurosurg Pediatr; 2014 Oct; 14(4):372-85. PubMed ID: 25127097
[TBL] [Abstract][Full Text] [Related]
30. Metastases to the central nervous system: Molecular basis and clinical considerations.
Wanleenuwat P; Iwanowski P
J Neurol Sci; 2020 May; 412():116755. PubMed ID: 32120132
[TBL] [Abstract][Full Text] [Related]
31. Practice-Changing Abstracts From the 2016 Society for Neuro-Oncology Annual Scientific Meeting.
Penas-Prado M
Am Soc Clin Oncol Educ Book; 2017; 37():187-191. PubMed ID: 28561706
[TBL] [Abstract][Full Text] [Related]
32. Marked improvement in leptomeningeal carcinomatosis and spinal cord metastases following alectinib treatment of crizotinib-resistant, ALK-positive lung adenocarcinoma.
Kuribayashi H; Abe S; Kuse N; Kusunoki Y; Narato R; Saito H; Gemma A
Int Cancer Conf J; 2016 Apr; 5(2):69-72. PubMed ID: 31149429
[TBL] [Abstract][Full Text] [Related]
33. Radiation necrosis presenting as pseudoprogression (PsP) during alectinib treatment of previously radiated brain metastases in ALK-positive NSCLC: Implications for disease assessment and management.
Ou SH; Klempner SJ; Azada MC; Rausei-Mills V; Duma C
Lung Cancer; 2015 Jun; 88(3):355-9. PubMed ID: 25882777
[TBL] [Abstract][Full Text] [Related]
34. Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Central Nervous System Metastases from Non-Small Cell Lung Cancer.
Ahluwalia MS; Becker K; Levy BP
Oncologist; 2018 Oct; 23(10):1199-1209. PubMed ID: 29650684
[TBL] [Abstract][Full Text] [Related]
35. Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group.
Camidge DR; Lee EQ; Lin NU; Margolin K; Ahluwalia MS; Bendszus M; Chang SM; Dancey J; de Vries EGE; Harris GJ; Hodi FS; Lassman AB; Macdonald DR; Peereboom DM; Schiff D; Soffietti R; van den Bent MJ; Wefel JS; Wen PY
Lancet Oncol; 2018 Jan; 19(1):e20-e32. PubMed ID: 29304358
[TBL] [Abstract][Full Text] [Related]
36. Neuro-oncology at the American Society for Clinical Oncology 2022 Annual Meeting.
Lukas RV; Chmura SJ; Parney IF; Mammoser A; Smith SM; Li J
Neurooncol Pract; 2022 Dec; 9(6):552-558. PubMed ID: 36388417
[TBL] [Abstract][Full Text] [Related]
37. Building Team Medicine in the Management of CNS Metastases.
Baskaran AB; Buerki RA; Khan OH; Gondi V; Stupp R; Lukas RV; Villaflor VM
J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373596
[TBL] [Abstract][Full Text] [Related]
38. The abscopal effect: systematic review in patients with brain and spine metastases.
Pangal DJ; Yarovinsky B; Cardinal T; Cote DJ; Ruzevick J; Attenello FJ; Chang EL; Ye J; Neman J; Chow F; Zada G
Neurooncol Adv; 2022; 4(1):vdac132. PubMed ID: 36199973
[TBL] [Abstract][Full Text] [Related]
39. Intracranial efficacy of alectinib in ALK-positive NSCLC patients with CNS metastases-a multicenter retrospective study.
Zou Z; Xing P; Hao X; Wang Y; Song X; Shan L; Zhang C; Liu Z; Ma K; Dong G; Li J
BMC Med; 2022 Jan; 20(1):12. PubMed ID: 35039026
[TBL] [Abstract][Full Text] [Related]
40. Immunotherapy for Neuro-oncology.
Majd NK; Dasgupta PR; de Groot JF
Adv Exp Med Biol; 2021; 1342():233-258. PubMed ID: 34972967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
